Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 247

1.

Improvement of process-of-care and outcomes after implementing a guideline for the management of community-acquired pneumonia: a controlled before-and-after design study.

Capelastegui A, España PP, Quintana JM, Gorordo I, Ortega M, Idoiaga I, Bilbao A.

Clin Infect Dis. 2004 Oct 1;39(7):955-63. Epub 2004 Sep 8.

PMID:
15472846
3.

Decreased mortality after implementation of a treatment guideline for community-acquired pneumonia.

Dean NC, Silver MP, Bateman KA, James B, Hadlock CJ, Hale D.

Am J Med. 2001 Apr 15;110(6):451-7.

PMID:
11331056
4.

Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit.

Frei CR, Attridge RT, Mortensen EM, Restrepo MI, Yu Y, Oramasionwu CU, Ruiz JL, Burgess DS.

Clin Ther. 2010 Feb;32(2):293-9. doi: 10.1016/j.clinthera.2010.02.006.

PMID:
20206787
5.

Tailored interventions to improve antibiotic use for lower respiratory tract infections in hospitals: a cluster-randomized, controlled trial.

Schouten JA, Hulscher ME, Trap-Liefers J, Akkermans RP, Kullberg BJ, Grol RP, van der Meer JW.

Clin Infect Dis. 2007 Apr 1;44(7):931-41. Epub 2007 Feb 20.

PMID:
17342644
6.

Processes of care, illness severity, and outcomes in the management of community-acquired pneumonia at academic hospitals.

Dedier J, Singer DE, Chang Y, Moore M, Atlas SJ.

Arch Intern Med. 2001 Sep 24;161(17):2099-104.

PMID:
11570938
7.

Guideline-concordant therapy and reduced mortality and length of stay in adults with community-acquired pneumonia: playing by the rules.

McCabe C, Kirchner C, Zhang H, Daley J, Fisman DN.

Arch Intern Med. 2009 Sep 14;169(16):1525-31. doi: 10.1001/archinternmed.2009.259.

PMID:
19752411
8.

Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis.

Ye X, Sikirica V, Schein JR, Grant R, Zarotsky V, Doshi D, Benson CJ, Riedel AA.

Clin Ther. 2008 Feb;30(2):358-71. doi: 10.1016/j.clinthera.2008.01.023.

PMID:
18343274
9.

Implementation of an inpatient management and discharge strategy for patients with community-acquired pneumonia.

Stone RA, Mor MK, Lave JR, Hough LJ, Fine MJ.

Am J Manag Care. 2005 Aug;11(8):491-9.

11.

Efficacy of clinical guideline implementation to improve the appropriateness of chest physiotherapy prescription among inpatients with community-acquired pneumonia.

Guessous I, Cornuz J, Stoianov R, Burnand B, Fitting JW, Yersin B, Lamy O.

Respir Med. 2008 Sep;102(9):1257-63. doi: 10.1016/j.rmed.2008.04.008. Epub 2008 Jul 10.

12.
13.
14.

[Evaluation of clinical practice in patients admitted with community-acquired pneumonia over a 4-year period].

Capelastegui A, España PP, Quintana JM, Gorordo I, Sañudo C, Bilbao A.

Arch Bronconeumol. 2006 Jun;42(6):283-9. Spanish.

15.

In-hospital observation after antibiotic switch in pneumonia: a national evaluation.

Nathan RV, Rhew DC, Murray C, Bratzler DW, Houck PM, Weingarten SR.

Am J Med. 2006 Jun;119(6):512.e1-7.

PMID:
16750965
16.

Impact of guideline-concordant empiric antibiotic therapy in community-acquired pneumonia.

Frei CR, Restrepo MI, Mortensen EM, Burgess DS.

Am J Med. 2006 Oct;119(10):865-71.

PMID:
17000218
17.

Understanding variation in quality of antibiotic use for community-acquired pneumonia: effect of patient, professional and hospital factors.

Schouten JA, Hulscher ME, Kullberg BJ, Cox A, Gyssens IC, van der Meer JW, Grol RP.

J Antimicrob Chemother. 2005 Sep;56(3):575-82. Epub 2005 Jul 27.

PMID:
16049096
18.

A comparison of levofloxacin and moxifloxacin use in hospitalized community-acquired pneumonia (CAP) patients in the US: focus on length of stay.

Schein J, Janagap-Benson C, Grant R, Sikirica V, Doshi D, Olson W.

Curr Med Res Opin. 2008 Mar;24(3):895-906. doi: 10.1185/030079908X273408.

PMID:
18419876
19.

Implementation of treatment guidelines to support judicious use of antibiotic therapy.

Deuster S, Roten I, Muehlebach S.

J Clin Pharm Ther. 2010 Feb;35(1):71-8. doi: 10.1111/j.1365-2710.2009.01045.x.

PMID:
20175814
20.

Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia.

Houck PM, Bratzler DW, Nsa W, Ma A, Bartlett JG.

Arch Intern Med. 2004 Mar 22;164(6):637-44.

PMID:
15037492

Supplemental Content

Support Center